Skip to main content
. 2019 Feb 21;33(7):1081–1089. doi: 10.1038/s41433-019-0375-5

Table 1.

Clinical characteristics of the study patients

Variable Non-CCD group, grade 0 CCD group, grades 1–3 95% CI of the difference Effect size γ Power, 1−β coefficient CCD grade CCD range
Grade 1 Grade 2 Grade 3 1 quadrant 2 quadrants 3 quadrants 4 quadrants
(n = 23) (n = 21) (n = 12) (n = 3) (n = 6) (n = 4) (n = 2) (n = 3) (n = 12)
Age, mean ± SD, years 76.9 ± 10.6 73.7 ± 10.1 −11.6 to 1.8 0.22 0.31 75.6 ± 10.5 72.3 ± 8.6 70.5 ± 10.8 82.0 ± 6.2 74.5 ± 13.4 64.0 ± 12.3 73.2 ± 9.0
Sex, Male/female, No 15/8 12/9 NA NA NA 6/6 2/1 4/2 3/1 2/0 0/3 7/5
Diagnosis, No
  Primary open-angle glaucoma 9 11 NA NA NA 7 1 3 3 1 2 5
  Normal tension glaucoma 7 6 NA NA NA 3 0 3 1 1 0 4
  Exfoliation glaucoma 7 4 NA NA NA 2 2 0 0 0 1 3
Axial length, mean ± SD, mm 24.2 ± 1.8 24.2 ± 1.4 −1.4 to 0.7 0.10 0.099 24.0 ± 1.4 23.8 ± 1.1 24.6 ± 1.7 23.8 ± 0.5 26.0 ± 1.3 24.4 ± 1.4 23.9 ± 1.5
Central corneal thickness, mean ± SD, μm 524.5 ± 21.0 509.1 ± 41.4 −31.4 to 11.7 0.14 0.14 510.8 ± 42.5 476.3 ± 58.8 522.2 ± 25.6 502 ± 47.4 509.0 ± 8.5 522.7 ± 55.9 508.1 ± 43.2
Visual field mean deviation, mean ± SD, dB −8.7 ± 6.4 −12.7 ± 11.0 −9.9 to 2.1 0.25 0.20 −8.2 ± 8.9 −25.8 ± 4.9 −15.5 ± 12.2 −14.5 ± 11.9 −8.6 ± 11.9 −2.5 ± 1.7 −15.5 ± 11.8
Surgical procedure, No
  Combined 18 17 NA NA NA 10 2 5 4 2 1 10
  Single 5 4 NA NA NA 2 1 1 0 0 2 2
Preoperative lens status, No.
  Phakia 18 21 NA NA NA 12 3 6 4 2 3 12
  Intraocular lens 5 0 NA NA NA 0 0 0 0 0 0 0
IOP, mean ± SD, mm Hg
  Preoperative 17.9 ± 5.3 17.1 ± 7.1 −2.9 to 4.7 0.072 0.074 17.4 ± 1.8 17.9 ± 3.7 16.0 ± 2.6 15.1 ± 1.8 13.9 ± 0.2 26.0 ± 16.9 16.0 ± 3.5
  Postoperative day 1 19.2 ± 12.8 11.9 ± 7.7 0.8 to 13.8 0.25 0.60 14.0 ± 3.1 7.7 ± 6.2 9.8 ± 4.4 19.3 ± 14.1 10.5 ± 0.7 12.3 ± 6.1 9.6 ± 4.6 
  Postoperative day 3 15.3 ± 6.4 12.4 ± 8.1 −1.5 to 7.3 0.20 0.25 15.1 ± 2.0 7.7 ± 4.1 9.3 ± 2.9 15.5 ± 11.8 18.0 ± 5.7 12.0 ± 4.0 10.5 ± 7.8
  Postoperative day 7 18.0 ± 9.3 13.8 ± 6.5 −0.8 to 9.1 0.38 0.38 15.4 ± 2.4 13.0 ± 4.7 11.0 ± 3.3 16.5 ± 8.2 17.0 ± 1.4 15.0 ± 7.0 12.1 ± 6.5
  Postoperative month 1 12.1 ± 3.5 15.7 ± 9.1 −7.7 to 0.5 0.26 0.12 15.7 ± 2.0 12.0 ± 3.9 17.7 ± 2.8 11.0 ± 2.9 21.0 ± 11.3 20.7 ± 9.7 15.2 ± 9.9
  Postoperative month 3 12.8 ± 4.4 13.0 ± 3.8 −2.7 to 2.5 0.016 0.050 13.1 ± 1.2 14.0 ± 2.4 12.0 ± 1.9 13.0 ± 3.5 11.0 ± 1.4 15.7 ± 7.2 12.5 ± 3.2
  Postoperative month 6 12.4 ± 2.6 12.8 ± 3.6 −2.3 to 1.0 0.056 0.064 13.6 ± 0.9 12.7 ± 1.8 10.8 ± 1.4 13.0 ± 2.0 12.5 ± 0.7 17.0 ± 7.0 11.5 ± 2.5
  Postoperative month 12 13.5 ± 3.9 13.0 ± 3.1 −1.6 to 2.7 0.075 0.076 13.9 ± 1.7 14.3 ± 2.0 10.5 ± 1.4 12.5 ± 1.0 14.5 ± 2.1 16.3 ± 2.9 12.1 ± 3.3
Glaucoma medication score, mean ± SD
  Preoperative 1.8 ± 1.8 2.9 ± 1.5 −2.1 to −0.1 0.32 0.56 2.8 ± 0.5 4.3 ± 0.9 2.5 ± 0.7 2.3 ± 0.4 3.5 ± 1.2 3.0 ± 1.0 3.0 ± 0.5
  Postoperative month 12 1.0 ± 1.3 0.8 ± 1.1 −0.5 to 0.4 0.080 0.080 1.0 ± 0.4 0.7 ± 0.7 0.5 ± 0.5 0.8 ± 0.6 0.5 ± 0.6 2.3 ± 0.7 0.5 ± 0.3
Visual acuity, mean ± SD, logMAR
  Preoperative 0.26 ± 0.21 0.37 ± 0.48 −0.32 to 0.11 0.054 0.16 0.29 ± 0.33 0.38 ± 0.40 0.53 ± 0.75 0.46 ± 0.42 0.55 ± 0.21 0.073 ± 0.20 0.38 ± 0.57
  Postoperative month 12 0.084 ± 0.22 0.050 ± 0.20 −0.094 to 0.16 0.017 0.083 −0.01 ± 0.10 0.032 ± 0.044 0.037 ± 0.082 −0.022 ± 0.12 0.07 ± 0.21 −0.027 ± 0.05 0.09 ± 0.24
Postoperative compications, No
  Postoperative hypotony 1 4 NA NA NA 0 1 3 0 0 0 4
  Postoperative hyphema 4 7 NA NA NA 1 1 5 0 0 1 6
  Postoperative IOP spike 9 5 NA NA NA 2 1 2 1 0 0 4

CCD ciliochoroidal detachment, IOP intraocular pressure, NA not applicable